|
1 |
Altered cortical synaptic lipid signaling leads to intermediate phenotypes of mental disorders
Tüscher, Oliver. - Augsburg : Universität Augsburg, 2024
|
|
|
2 |
Development and multi-center validation of a fully automated digital immunoassay for neurofilament light chain: toward a clinical blood test for neuronal injury
Enthalten in Clinical chemistry and laboratory medicine Bd. 62, 2024, Nr. 2: 322-331. 10 S.
|
|
|
|
3 |
Altered cortical synaptic lipid signaling leads to intermediate phenotypes of mental disorders
Enthalten in Molecular psychiatry 28.5.2024: 1-16
|
|
|
|
4 |
Early spinal cord pseudoatrophy in interferon‐beta‐treated multiple sclerosis
Matusche, Britta. - Augsburg : Universität Augsburg, 2023
|
|
|
|
5 |
Factors associated with depressive mood at the onset of multiple sclerosis - an analysis of 781 patients of the German NationMS cohort
Salmen, Anke. - Augsburg : Universität Augsburg, 2023
|
|
|
|
6 |
AgRP neurons control feeding behaviour at cortical synapses via peripherally derived lysophospholipids
Endle, Heiko. - Augsburg : Universität Augsburg, 2022
|
|
|
|
7 |
Altered grey matter integrity and network vulnerability relate to epilepsy occurrence in patients with multiple sclerosis
Ciolac, Dumitru. - Augsburg : Universität Augsburg, 2022
|
|
|
|
8 |
Association of obesity with disease outcome in multiple sclerosis
Lutfullin, Isabel. - Augsburg : Universität Augsburg, 2022
|
|
|
|
9 |
Comparative effectiveness of natalizumab versus ocrelizumab in multiple sclerosis: a real-world propensity score–matched study
Pape, Katrin. - Augsburg : Universität Augsburg, 2022
|
|
|
|
10 |
Early spinal cord pseudoatrophy in interferon-beta-treated multiple sclerosis
Matusche, Britta. - Bochum : Ruhr-Universität Bochum, 2022
|
|
Administration
